Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

A profusion of confusion in NGS methods naming

Nature Methods volume 15, pages 7–8 (2018)Cite this article

Subjects

 To the Editor:

Few branches of the biological sciences have remained untouched by the rapid adoption of next-generation sequencing (NGS). Sequencing can be used to study single cells, identify archeological remains, or monitor tumor heterogeneity in the clinic. Almost anything seems possible, if only we can find the right method.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Retief, J. D. and Maxkwee K. For all you seq, https://www.illumina.com/content/dam/illumina-marketing/documents/applications/ngs-library-prep/ForAllYouSeqMethods.pdf (Illumina, 2014).

    Google Scholar 

  2. Anonymous. Nat. Methods 8, 521 (2011).

  3. Tang, F. et al. Nat. Methods 6, 377–382 (2009)

    Article  CAS  Google Scholar 

  4. Crosetto, N. et al. Nat. Methods 10, 361–365 (2013).

    Article  CAS  Google Scholar 

  5. Ali, O.A. et al. Genetics 202, 389–400 (2016).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We acknowledge the contribution of the many authors whose methods are referenced in this manuscript and apologize that restrictions on the number of references meant we did not list their work.

Author information

Authors and Affiliations

  1. Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK

    James Hadfield

  2. Precision Medicine and Genomics, IMED Biotech Unit, AstraZeneca, Cambridge, UK

    James Hadfield

  3. Illumina Inc., San Diego, California, USA. Precision Medicine and Genomics, IMED Biotech Unit, AstraZeneca, Cambridge, UK

    Jacques Retief

Authors
  1. James Hadfield
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jacques Retief
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to James Hadfield.

Ethics declarations

Competing interests

James Hadfield is the owner of the Enseqlopedia.com domain. Jacques Retief is currently employed by and owns shares in Illumina Inc., San Diego, California, USA.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hadfield, J., Retief, J. A profusion of confusion in NGS methods naming. Nat Methods 15, 7–8 (2018). https://doi.org/10.1038/nmeth.4558

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nmeth.4558

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research